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Abstract
The German Commission for the Investigation of Health Hazards of Chemical Com-
pounds in the Work Area has re-evaluated the maximum concentration at the work-
place (MAK value) of 1‑butanethiol [109-79-5]. Available publications and unpub-
lished study reports are described in detail. Additional data from a 90-day inhalation
study in rats indicate that the critical effect is haematotoxicity. On the basis of the
NOAEC of 9 ml/m3 and taking into account the increased respiratory volume at the
workplace, the MAK value is increased to 1 ml/m3. Since a systemic effect is critical,
Peak Limitation Category II with an excursion factor of 2 is assigned.The NOAEC for
developmental toxicity in mice is 10 ml/m3 and the NOEC for rats is 152 ml/m3. Af-
ter considering the increased respiratory volume at the workplace, the margin to the
MAK value calculated based on the data from the rat is sufficiently large. In mice, the
LOAEC for developmental toxicity is 68 ml/m3 and the NAEC is probably higher than
10 ml/m3, which results in a sufficient margin to theMAK value.Therefore, damage to
the embryo or foetus is unlikely if the MAK value is not exceeded and 1‑butanethiol
remains classified in Pregnancy Risk Group C. According to skin absorption models,
percutaneous absorption is expected to contribute significantly to systemic toxicity.
Therefore, 1‑butanethiol is designated with an “H”. 1‑Butanethiol can cause sensiti-
zation of the skin in animals and is therefore designated with “Sh”.
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MAK value (2019) 1 ml/m3 ≙ 3.7 mg/m3
Peak limitation (2019) Category II, excursion factor 2
Absorption through the skin (2018) H
Sensitization (2018) Sh
Carcinogenicity –
Prenatal toxicity (2000) Pregnancy Risk Group C




Vapour pressure at 25 ℃ 60.7 hPa (NLM 2018)
log KOW 2.28 (NLM 2018)
Solubility at 20 ℃ 597 mg/l water (NLM 2018)
1 ml/m3 (ppm) ≙ 3.742 mg/m3 1 mg/m3 ≙ 0.267 ml/m3 (ppm)
For 1‑butanethiol, documentation from 2000 and a supplement on peak limitation from 2002 (Greim 2005, combined
in one translation) are available.
In 2016, the Commission began using a revised approach for assessing substances with a MAK value based on
systemic effects and derived from inhalation studies in animals or studies with volunteers at rest; this new approach
takes into account that the respiratory volume at the workplace is higher than under experimental conditions.
However, this does not apply to gases or vapour with a blood:air partition coefficient of < 5 (see List of MAK and
BAT Values, Sections I b and I c). According to the formula of Buist et al. (2012), the blood:air partition coefficient
of 1‑butanethiol is 23.1. This supplement evaluates whether the MAK value and the Pregnancy Risk Group for
1‑butanethiol need to be re-assessed as a result of the higher respiratory volume at the workplace.
For certain end points, also data for other thiols with a similar structure are included.
Mechanism of Action
As already described in the documentation of 2000 (Greim 2005), in the presence of suitable metal ions thiols can
contribute to the formation of reactive oxygen species by autoxidation.The resulting disulfides can be reduced again
to thiols. This redox cycling can lead to oxidative stress. Aliphatic thiols have a haemolytic effect, recognizable by
the presence of Heinz bodies in the erythrocytes, which are formed by irreversibly denatured haemoglobin. As
a result, the number of erythrocytes decreases as they lose their deformability and are destroyed in the reticulo-
histiocytic system. Erythroclasia occurs mainly in the spleen, recognizable by enlargement and dark discoloration.
A decrease in circulating erythrocytes stimulates compensatory erythropoiesis, but if too few new erythrocytes are
formed this can lead to anaemia (Munday 1989).
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Toxicokinetics and Metabolism
On the basis of toxicity studies in animals, absorption by the respiratory and gastrointestinal tract is to be assumed.
However, quantitative data are not available (Greim 2005).There are also no quantitative studies available for dermal
absorption. With mathematical models, a dermal flux of 0.27 mg/cm2 and hour (Fiserova-Bergerova et al. 1990) or
0.01 mg/cm2 and hour (Guy and Potts 1993; Wilschut et al. 1995) can be calculated. After the exposure of a skin area
of 2000 cm2 to a saturated aqueous solution for one hour, the total amount absorbed is thus between 20 mg and
540 mg.
It is generally known that mercaptans are oxidized in the liver, whereby, among other substances, sulfides and
sulfates are formed (Farr and Kirwin 1994; Greim 2005).
Animal Experiments and in vitro Studies
Acute toxicity
Inhalation
LC50 values for 1‑butanethiol after 4‑hour inhalation exposure were reported to be 4020 and 6060 ml/m3 for the rat
and 2500 ml/m3 for the mouse. They are thus in the same order of magnitude as those of ethanethiol at 4420 ml/m3
and 2770 ml/m3 for the rat and mouse, respectively. For 1‑propanethiol, the values are slightly higher (rat: 7300 or
> 8170 ml/m3, mouse: 4010 ml/m3). The 4‑hour LC50 values of 2‑methyl-2-propanethiol are much higher (rat: 22 220
or 26 643 ml/m3; mouse: 16 500 ml/m3). Lacrimation, hunched posture, tremor, staggering gait, muscular weakness,
cyanosis and sedation, and also mucous membrane irritation (rubbing of eyes and nose, eye closure, watering of
the eyes, corneal opacity) and retraction of the head were observed (OECD 2010).
Oral administration
The oral LD50 of 1‑butanethiol is 1500 mg/kg body weight for the rat and is thus similar to the values for
1‑propanethiol of 1790 and 1848 mg/kg body weight. The value for ethanethiol is lower (682 mg/kg body weight),
that for 2‑methyl-2-propanethiol higher (4756 mg/kg body weight). Ruffled fur, lacrimation, staggering, bloody
stains around the nose and sedation were observed in the animals (OECD 2010).
Dermal application
The dermal LD50 value for 1‑butanethiol is greater than 2000 mg/kg body weight, as is that for ethanethiol,
1‑propanethiol and 2‑methyl-2-propanethiol. For 1‑butanethiol and ethanethiol these values were obtained in the
rat, while for 1‑propanethiol and 2‑methyl-2-propanethiol studies were carried out in the rabbit. Apart from skin
reactions, no effects were observed (OECD 2010).
Subacute, subchronic and chronic toxicity
Inhalation
Since the documentation of 2000 (Greim 2005), no new studies with 1‑butanethiol have been conducted. However,
the results of histopathological follow-up studies (Phillips Chemical Company 1983, 1984) of the 90-day inhalation
study (Phillips Chemical Company 1982) have been evaluated, which were not available in 2000. The studies of
repeated inhalation exposure of rats to 1‑butanethiol are shown in Table 1.
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0, 204, 1114, 1900 ml/m3,
6 hours/day, 7 days/week,
dose-finding,
(histopathological examination only of
the kidneys, only at 1900 ml/m3)
≥ 204 ml/m3: relative kidney weights ↑; ♂: relative weights of lungs
and trachea ↑
≥ 1114 ml/m3: body weight development ↓; ♀: relative weights of
spleen, lungs, trachea and heart ↑, dark-coloured kidneys; 1/20 died
1900 ml/m3: clinical signs (tremor, respiratory distress, lacrimation),










0, 9, 70, 150 ml/m3,
6 hours/day, 5 days/week,
(histopathological examination only at
0, 150 ml/m3; follow-up examination
of kidneys and lungs: 9 and 70 ml/m3,
lungs: additional repeated examination
0, 150 ml/m3)
9 ml/m3: NOAEC for systemic effects
70 ml/m3: follow-up examination: evidence of Sendai virus due
to chronic multifocal interstitial pneumonia (perivascular and
peribronchiolar distribution with focal interstitial infiltration with
lymphocytes, plasma cells and macrophages – no macrophages in
pulmonary regions without this damage); ♂: absolute weights of
trachea and lungs ↑
NOAEC for local effects
≥ 70 ml/m3: ♂: relative weights of trachea and lungs ↑; ♀: erythro-
cytes ↓ (week 12), haemoglobin ↓
150 ml/m3: alveolar macrophages ↑ (11/15 ♂, 12/15 ♀; follow-up
examination), “interstitial pulmonary fibrosis”, diagnosed in follow-up
examination as an artifact of tissue processing; ♂: inflammation in






In the 13-week inhalation study already described in detail in the documentation of 2000 (Greim 2005), in which
15 Sprague Dawley rats per sex and group were exposed to 1‑butanethiol concentrations of 0, 9, 70 or 150 ml/m3 for
6 hours daily, on 5 days per week, the NOAEC (no observed adverse effect level) for systemic effects was 9 ml/m3.
At the two higher concentrations, a slight but statistically significant decrease in the number of erythrocytes was
observed in the female animals in the sixth (150 ml/m3) and twelfth week (at 70 ml/m3 and above) which correlated
with a slight decrease in haemoglobin. At 150 ml/m3, the number of neutrophils increased and that of lymphocytes
decreased. The changes were within the range of the historical control data of the laboratory and were therefore
assessed by the authors as not related to the treatment. However, since these effects, in particular the decrease
in the erythrocyte count, are characteristic of thiols (see Section “Mechanism of Action”), they are considered by
the Commission to be treatment-related. At the concentrations 70 ml/m3 and 150 ml/m3, there was a statistically
significant increase in the relative lung weights in the male animals (absolute weights only in the middle group),
and slight to moderate fibrosis of the lungs was reported in rats of both sexes at 150 ml/m3. Histopathological ex-
amination was initially performed only in the controls and the high concentration group (see Greim 2005; Phillips
Chemical Company 1982). In a follow-up examination, histological sections of the kidneys and lungs were evalu-
ated for the two remaining groups. For the lungs, the controls and high concentration group were also re-evaluated.
In the middle concentration group, evidence of a Sendai virus infection was obtained, as chronic multifocal inter-
stitial pneumonia was observed in the affected animals. The affected areas were characterized by perivascular
and peribronchiolar distribution with focal interstitial infiltration of lymphocytes, plasma cells and macrophages.
Macrophages were detected only in the affected lung areas. The animals of the other treatment groups were not
affected. Substance-related lung effects were observed in the animals of the 150 ml/m3 group which showed an in-
crease in alveolar macrophages. The “interstitial lung fibrosis” diagnosed in the original evaluation was interpreted
as an artifact of tissue processing (Phillips Chemical Company 1983, 1984). Since in the high concentration group 2
of 15 animals displayed inflammation in the nasal turbinates and considerably more animals exhibited lung effects
(male animals: 11/15, female animals: 12/15), it can be assumed that the lungs are more sensitive than the upper
respiratory tract. For this reason, 70 ml/m3 is regarded as the NOAEC for local effects in the lungs and the nose.
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The analogue 2‑methyl-2-propanethiol was tested at the same time under the same conditions. The concentra-
tions used were 0, 9, 97 and 196 ml/m3. Changes in haematological parameters likewise occurred, but were inter-
preted by the authors of the study as not biologically relevant. The number of erythrocytes in the female animals
decreased at 97 ml/m3 and above. The absolute and relative kidney weights of the male animals were increased; this
was probably the result of chronic nephrosis (see below) (Phillips Chemical Company 1982). Here, too, a follow-up
examination with the evaluation of histological sections of the kidneys and lungs was performed for all groups. In
the kidneys of the male animals, chronic nephrosis was observed in all groups exposed to 2‑methyl-2-propanethiol
(9, 97, 196 ml/m3: 3/15, 13/14, 14/15) (Phillips Chemical Company 1983, 1984); this was attributed to α2u-globulin
nephropathy. As this is species-specific, it is not relevant for humans. In the study itself, there was no immuno-
histochemical evidence of α2u-globulin, but evidence was found in the screening study described in the Section
“Oral administration”.
The NOAEC for systemic effects in both studies, based on haematological changes typical of thiols, such as
a decrease in the erythrocyte count, was 9 ml/m3. The females were found to be more sensitive than the males.
For 1‑butanethiol the NOAEC for local effects was 70 ml/m3; at 150 ml/m3 there was a significant increase in alveo-
lar macrophages in the lungs.
In a 90-day inhalation study carried out according to OECD Test Guideline 413, 10 Sprague Dawley rats per sex and
group were exposed whole-body to 2‑butanethiol concentrations of 0, 25, 99 or 400 ml/m3 for 6 hours daily, on
5 days per week. After exposure to 99 ml/m3, haemosiderin accumulation in the spleen and eosinophilic inclusions
in the nasal turbinates were observed in the male animals; this reached statistical significance only at the high
concentration. Another target organ is the kidney, in which hyaline droplets in the tubules, granular inclusions,
pyelonephritis and tubular degeneration or regeneration were observed in the male animals of the 400 ml/m3 group;
pyelonephritis was found also in the female animals. Immuno-histochemical staining of α2u-globulin was not
performed (Kim et al. 2009). Effects were thus initially observed at 99 ml/m3, so that, contrary to the authors’
statement, the NOAEC in this study was 25 ml/m3. The changes in the animals’ noses are regarded as a consequence
of the irritant effect of 2‑butanethiol.
Oral administration
No studies with 1‑butanethiol are available.
In a screening study according to OECD Test Guideline 422, 12 male and 17 female Sprague Dawley rats per group
were given gavage doses of 2‑methyl-2-propanethiol of 0, 10, 50 or 200 mg/kg body weight and day on 7 days
a week (5 of the female animals were used to investigate developmental toxicity). Treatment began 14 days before
mating and lasted for a total of 6 weeks in the males and 7 weeks in the females (until the 4th day after birth).
Satellite groups of 5 animals for the control group and the 200 mg/kg body weight group, consisting of 5 female
animals which were not pregnant and 5 male animals, were examined 12 days after the end of the treatment. Effects
on the kidneys were observed in the male animals of all treatment groups. These effects were due to immuno-
histochemically proven α2u-globulin nephropathy and are therefore not relevant for humans. At 50 mg/kg body
weight and day and above, hepatocellular centrilobular hypertrophy and periportal fatty degeneration of the liver
as well as increased absolute and relative liver weights were observed in the male animals (50, 200 mg/kg body
weight: +29%, +41% compared with the control values (absolute), +35%, +64% compared with the control values
(relative)). In the high dose group, changes in haematological and clinico-chemical parameters were observed in
both sexes in addition to delayed body weight gains and reduced feed intake (see Table 2). Haemosiderin deposits
were observed in the spleen. Hepatocellular, centrilobular hypertrophy was observed in the liver of the female
animals. The α2u-globulin nephropathy observed in male rats at and above 10 mg/kg body weight and day is not
considered relevant for humans. Therefore, the NOAEL (no observed adverse effect level) of this study is 10 mg/kg
body weight and day for the male animals and 50 mg 2‑methyl-2-propanethiol/kg body weight and day for the
female animals (MHLW 2006).
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0, 10, 50, 200 mg/kg body weight
and day in corn oil,
7 days/week,
gavage,
OECD Test Guideline 422
10 mg/kg body weight: ♂: swollen and pale kidneys (1/12), NOAEL
≥ 10 mg/kg body weight: ♂: absolute and relative kidney weights ↑,
hyaline droplets in the proximal tubular epithelium (dose-dependent
increase in severity), basophilic renal tubules ↑ (demonstrated α2u-globulin
nephropathy)
50 mg/kg body weight: ♀: NOAEL
≥ 50 mg/kg body weight: cholesterol ↑, absolute and relative liver
weights ↑ (by 29% and 35%, respectively, compared with values for
controls); ♂: hepatocellular, centrilobular hypertrophy, periportal fatty
degeneration of hepatocytes, swollen and pale kidneys (3/12), MCHC ↓,
phospholipids ↑
200 mg/kg body weight: body weight development ↓, food uptake ↓,
erythrocytes ↓, glucose ↓, α1-globulin ↓, albumin ↑, phospholipids ↑,
haemosiderin deposits in spleen; ♂: Hb ↓, haematocrit ↓, thrombocytes ↓,
α2u-globulin ↑, γ‑GTP ↑, swollen liver (2/12), swollen and pale kidneys
(4/12), absolute thymus weights ↓; ♀: reticulocytes ↑, total protein
content ↑, A/G ratio ↑, hepatocellular, centrilobular hypertrophy, absolute
and relative liver weights ↑
no effects in FOB examination
MHLW 2006
A/G: albumin/globulin ratio; FOB: functional observational battery; GTP: γ‑glutamyl transpeptidase; Hb: haemoglobin; MCHC: mean cellular
haemoglobin concentration
Summary
Target organs of the tested thiols are the haematopoietic system, the liver and in male rats the kidneys. How-
ever, the effects on the kidneys are species and sex-specific and therefore not relevant for humans. The systemic
NOAEC is 9 ml/m3 for 1‑butanethiol and 2‑methyl-2-propanethiol and 25 ml/m3 for 2‑butanethiol. In two simul-
taneously performed inhalation studies in rats with 1‑butanethiol and 2‑methyl-2-propanethiol and subsequent
histopathology of the lungs of all animals, the local NOAEC for 1‑butanethiol was 70 ml/m3, that for 2‑methyl-
2-propanethiol 9 ml/m3, due to a significant increase in alveolar macrophages at 150 ml 1‑butanethiol/m3 and at
97 ml 2‑methyl-2-propanethiol/m3 and above. In a 90-day inhalation study, eosinophilic inclusions in the olfactory
epithelium occurred at 99 ml 2‑butanethiol/m3, the NOAEC was 25 ml/m3.
Local effects on skin and mucous membranes
The occlusive application of 0.5 ml 1‑butanethiol to the intact shaved skin of 6 rabbits for 4 hours did not lead to
any skin reactions (OECD 2010).
The instillation of 0.1 ml 1‑butanethiol into the eye of a rabbit led to slight irritant effects (no other details; Fairchild
and Stokinger 1958). However, damage to the iris within the first 14 hours and slight to moderate conjunctival
irritation for up to 72 hours after application have also been reported (no other details; Farr and Kirwin 1994).
Allergenic effects
In a local lymph node assay (LLNA) according to OECD Test Guideline 429, 1‑butanethiol (purity 99.2%) yielded
positive results. Groups of 4 female CBA/J mice were treated with 5%, 10%, 25% and 50% test substance preparations
in acetone:olive oil (4 : 1) and with the undiluted substance. The corresponding stimulation indices were 0.67, 0.43,
2.45, 5.38 and 14.4; thus, a tripling of the stimulation index, compared with the value for the controls, was exceeded
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with the 50% and 100% solution. The EC3 value (concentration required to triple lymphocyte proliferation) is 30%.
The undiluted solution resulted in dry skin and a slight increase in ear thickness in all 4 animals (15.15% increase
in ear thickness between day 1 and day 6) and an erythematous reaction in 1 animal. In preliminary experiments
with the undiluted substance no irritant effects were observed in 2 animals (Arkema France & Chevron Phillips
Chemical Company LP 2011 a).
In an LLNA performed in the same way with 2‑methyl-2-propanethiol (purity 98.71%), stimulation indices of
1.73, 1.77, 3.62, 4.26 and 30.43 were determined without any increase in ear thickness. From this, an EC3 value of
20% was calculated (Arkema France & Chevron Phillips Chemical Company LP 2011 b).
In a Buehler test with 2‑methyl-2-propanethiol in 10 female and 10 male Hartley guinea pigs, the undiluted
substance was used for induction treatment. The challenge treatment was carried out with a 75% preparation of the
test substance in mineral oil. After both 24 and 48 hours, weak to marked reactions (grades 1 to 3) were observed
in all 20 animals. In the 10 control animals, weak reactions were observed in 10 and 9 of the animals after 24 and
48 hours, respectively (Elf Atochem 1995).
There is also an incompletely documented test with 10 guinea pigs available; an erythematous reaction was reported
in 1 of the 10 animals only 24 hours, but not 48 and 72 hours after challenge with 25% 1‑butanethiol in acetone.
Induction treatment was performed with a 50% preparation of the test substance in the same vehicle (Phillips
Petroleum Company 1982). As the substance was not characterized in detail, the frequency of the induction
treatment is not apparent and it is not possible to determine whether induction treatment was open or occlusive,
this result cannot be used for the evaluation.
This applies also to the results of an open patch test in 5 female and 5 male guinea pigs with application of a 20%
1‑butanethiol preparation in acetone, already cited in the documentation of 2000 (Greim 2005). The test prepara-
tion (0.2 ml) was applied to one flank of each of the animals for up to 10 consecutive days or until signs of contact
dermatitis appeared. One month later, challenge treatment with the same test preparation was performed on the
other flank. While single applications of dodecanethiol and octanethiol already led to signs of sensitization in about
half of the animals, the result with 1‑butanethiol was negative even after 10 days (Cirstea 1972).
Reproductive and developmental toxicity
Fertility
In the screening study according to OECD Test Guideline 422 described in detail in the section “Subacute,
subchronic and chronic toxicity” and Table 2, in which Sprague Dawley rats were treated with 2‑methyl-2-
propanethiol doses of 0, 10, 50 or 200 mg/kg body weight and day, no effects on the reproduction parameters
mating index (high dose group 11/12), duration of mating, duration of pregnancy, implantation index, number of
pups, number of live pups, 4‑day survival index and sex ratio were found. The histopathological examination of the
reproductive organs did not reveal any unusual, substance-related findings. The NOAEL for fertility in this study
was 200 mg/kg body weight and day, which was the highest dose tested (MHLW 2006).
Developmental toxicity
Developmental toxicity studies after inhalation exposure of rats and mice are available, which are described in
detail in the documentation of 2000 (Greim 2005). In the CD‑1 mouse, inhalation of 68 ml 1‑butanethiol/m3 caused
lethality and an increased incidence of malformations (especially cleft palates) with simultaneous maternal toxicity
in the form of delayed body weight gains and mortality. The NOAEC for developmental toxicity is 10 ml/m3 for the
mouse and the NOAEC for the rat is 152 ml/m3, which was the highest concentration tested (Greim 2005).
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The screening study with 2‑methyl-2-propanethiol according to OECD Test Guideline 422 described in the sec-
tions “Subacute, subchronic and chronic toxicity” and “Fertility” is not used for the evaluation of the developmental
toxicity, as studies with 1‑butanethiol itself are available.
Manifesto (MAK value/classification)
Critical are the effects on the erythrocytes, the lungs and the liver, possibly also irritation of the mucous membranes
and the odour.
MAK value. The previously valid, provisional MAK value of 0.5 ml/m3 was derived in analogy to that for methyl
mercaptan (methanethiol). In the meantime, the MAK value of methyl mercaptan has been re-evaluated and con-
firmed (see Hartwig and MAK Commission 2020).
As with all thiols, 1‑butanethiol is a substance with a strong, unpleasant odour. Due to the low perception threshold
of between 0.0001 and 0.01 ml 1‑butanethiol/m3 (Greim 2005), the odour effect is probably the most important factor,
but it is unclear at which concentration the unpleasant odour of 1‑butanethiol represents an intolerable nuisance
for humans.
In the 90-day inhalation study with 1‑butanethiol in Sprague Dawley rats, the most sensitive end point is a decrease
in the erythrocyte count, correlated with a slight decrease in the haemoglobin content, with a LOAEL (lowest
observed adverse effect level) of 70 ml/m3 and a NOAEC of 9 ml/m3. Since this NOAEC is derived from animal
experiments (1 : 2), and taking into account the increased respiratory volume at the workplace (1 : 2) and a possible
increase in the effect with increasing exposure duration (1 : 2), a MAK value of 1 ml/m3 is obtained for 1‑butanethiol
after application of the preferred value approach.
Similar systemic effects were observed in several studies with inhalation exposure of rats to 1‑butanethiol and
other butanethiols. The NOAECs obtained in these studies are of the same order of magnitude (Table 3). The MAK
value of 1 ml 1‑butanethiol/m3 also avoids local effects, as can be seen from the data with 1‑butanethiol and from
the comparison with the data of 2‑methyl-2-propanethiol and 2‑butanethiol (Table 3).
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Tab. 3 Summary of results from available studies with 1-butanethiol, 2-methyl-2-propanethiol and 2-butanethiol in rats and the MAK

























































a) Calculation for inhalation: NOAEC / 2 (extrapolation from animal studies to humans) / 2 (increased respiratory volume of humans
at the workplace in the case of systemic effects) / 2 (extrapolation to chronic exposure), subsequent application of the preferred value approach
b) Calculation for oral administration: NOAEL / 4 (kinetics) / 4 (extrapolation to chronic exposure) / 2 (extrapolation from animal studies to
humans) × 70 kg body weight / 10 m3 (respiratory volume per working day) × 7/5 (for daily exposure compared with 5 days/working week),
subsequent application of the preferred value approach
Peak limitation. Since the MAK value for 1‑butanethiol was derived from systemic effects, the substance is
assigned to Peak Limitation Category II. No information on the half-life is available.Therefore, the default excursion
factor of 2 for substances with systemic effects has been set. This means that the permissible short-term peak
concentration is also below the calculated limit value for the local effect (Table 3).
Prenatal toxicity. For the evaluation of developmental toxicity, only studies with 1‑butanethiol are used.
Developmental toxicity studies in rats and mice are available, which were already described in detail in the docu-
mentation of 2000 (Greim 2005). In the CD‑1mouse, inhalation of 68 ml/m3 led to lethality and an increased incidence
of malformations (cleft palates) with simultaneous maternal toxicity in the form of delayed body weight gains and
mortality. The NOAEC for developmental toxicity is 10 ml/m3 for the mouse and the NOAEC for the rat is 152 ml/m3,
the highest concentration tested. This led to the assignment of 1‑butanethiol to Pregnancy Risk Group C in 2000.
Taking into account the increased respiratory volume (1 : 2), the NOAECs for developmental toxicity in rats and
mice are, respectively, 76 and 5 times as high as the MAK value of 1 ml/m3. The LOAEC (lowest observed adverse
effect concentration) for developmental toxicity in mice is 34 times the MAK value. Thus, the NOAEC could also be
higher. In view of this, together with the sufficiently large margin of the NOAEC obtained from the developmental
toxicity study in rats to the MAK value of 1 ml/m3, the assignment of 1‑butanethiol to Pregnancy Risk Group C has
been retained.
Absorption through the skin. Calculations based on physicochemical data and mathematical models yield
values for dermal absorption of between 20 mg and 540 mg 1‑butanethiol under standard conditions. From the
systemic NOAEC of 1.1 ml/m3 (4.2 mg/m3) derived for the workplace (Table 3, before application of the preferred
value approach), a tolerable amount of about 42 mg is calculated for that absorbed by inhalation assuming complete
pulmonary absorption and a respiratory volume of 10 m3. Dermal absorption can therefore account for more than
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25% of the systemically tolerable amount, so that 1‑butanethiol has been designated with an “H” (for substances
which can be absorbed through the skin in toxicologically relevant amounts).
Sensitization. There are no findings of skin sensitization caused by 1‑butanethiol in humans. A positive re-
sult in a valid local lymph node assay (LLNA) indicated that 1‑butanethiol has a low sensitization potential. The
structurally very similar 2‑methyl-2-propanethiol yielded a similar result in the LLNA. Data for respiratory sen-
sitization are not available. 1‑Butanethiol is therefore designatedwith “Sh” (for substances which cause sensitization
of the skin) but not with “Sa” (for substances which cause sensitization of the airways).
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